Daniel Gonzalez
PharmD, PhD, Associate Professor, Division of Clinical Pharmacology, Department of Medicine, Duke
Dr. Gonzalez's research focuses on applying quantitative pharmacology techniques to characterize the pharmacokinetics and pharmacodynamics of drugs, guide drug dosage selection, and improve drug safety in children.
Bridgette L. Jones
MD, MSCR, Professor of Pediatrics at University of Missouri-Kansas City School of Medicine and at Children’s Mercy Kansas City in the Section of Allergy/Asthma/Immunology and Division of Pediatric Clinical Pharmacology and Therapeutic Innovation.
Dr. Jones is an allergy/asthma and pediatric clinical pharmacology researcher focused on evaluating pharmacologic therapies and treatment response in children with asthma and allergic disease.
Adriana Tremoulet
MD, MAS, Professor, UCSD
Dr. Tremoulet’s research focuses on repurposing therapeutics in Phase I through III clinical trials, especially in the field of inflammatory and infectious diseases. She is the co-PI of UCSD’s NICHD-funded Pediatric Clinical Pharmacology T32 program, co-director of the NIH-funded Altman Clinical Trials Research Institute KL2 program, and co-PI of the NICHD-funded Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub.
Daniel K. Benjamin Jr.
MD, PhD, MPH, Kiser-Arena Distinguished Professor of Pediatrics, Duke, and Deputy Director, Duke Clinical Research Institute (DCRI).
Dr. Benjamin is a pediatric infectious disease physician-scientist and Chair of the Pediatric Trials Network, and his research interests include optimizing the safe and effective use of anti-infective agents in the pediatric population.